Three-in-five want to get COVID-19 vaccine but still a reluctance among some Aussies, study finds - 9News

Nearly three-in-five Australians say they will definitely receive a coronavirus vaccine once it is available, a study has found.

In contrast, people who are more religious, those living in disadvantaged regions and people with populist outlooks were less likely to get the jab.

The new analysis by the Australian National University is the first nationally representative survey of attitudes towards a COVID-19 vaccine.

A national survey has showed some people are reluctant to get a coronavirus vaccine but early three-in-five Australians say they will definitely get one. (AP)

It showed people with higher levels of household income, those who follow public health guidance and people who favour migration were more likely to become vaccinated.

Almost three in five Australians (58.5 per cent) said they would definitely get a vaccine once it was available, and 6 per cent said they definitely would not. A further 7 per cent said they probably would not.

Researchers found women were slightly less likely than men to receive the vaccine, while those aged 55 and older were less cautious about getting it than those aged 35 to 44.

Health experts have said an effective COVID-19 vaccine that can be rolled out quickly to the entire population will be a major weapon in stemming the pandemic.

Deeply religious people were less likely to get a coronavirus vaccine, an Australian study has found. (AP)

But study co-author Professor Nicholas Biddle said the survey showed there was reluctance to get vaccinated among some Australians.

"Our findings show vaccine hesitancy, which accounts for a significant proportion of the population, may be addressed by public health messaging.

"But for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic."

Scientists have reported progress in developing a coronavirus vaccine.

University of Oxford scientists have released a study that found the vaccine it is developing with the drugmaker AstraZeneca was well tolerated and produced a strong immune response in people over 70.

And pharmaceutical companies Pfizer and Moderna this week reported preliminary results from late-stage trials showing that their COVID-19 vaccines were almost 95 per cent effective.

Let's block ads! (Why?)

https://news.google.com/__i/rss/rd/articles/CBMihgFodHRwczovL3d3dy45bmV3cy5jb20uYXUvaGVhbHRoL2Nvcm9uYXZpcnVzLXZhY2NpbmUtc3R1ZHktZmluZHMtc29tZS1hdXN0cmFsaWFucy1yZXNpc3RhbnQtdG8tamFiL2Y2ZDdjMmZkLWQyZWEtNGVmNi04NTgwLWJkMzBhNjg3ZDY2ZdIBRWh0dHBzOi8vYW1wLjluZXdzLmNvbS5hdS9hcnRpY2xlL2Y2ZDdjMmZkLWQyZWEtNGVmNi04NTgwLWJkMzBhNjg3ZDY2ZQ?oc=5

2020-11-20 01:40:00Z
52781198568331

Bagikan Berita Ini